HRA Pharma & Celnova Pharma partner to launch medicines in South America for adrenocortical carcinoma

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

HRA Pharma Rare Diseases, a business of Perrigo Company, signed a partnership with Celnova Pharma, to ensure that the products developed by HRA Pharma Rare Diseases can be successfully registered and launched across Argentina, Chile, and Peru.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login